Global (North America, Europe, Asia-Pacific, South America, Middle East and Africa) Chemotherapy-induced Nausea and Vomiting Drugs Market 2018, Forecast to 2023

November 2018 | 150 pages | ID: G073E6217C3EN
GlobalInfoResearch

Abstracts

Chemotherapy induced nausea and vomiting (CINV) drugs refer to medication or treatment that is offered to cancer patients who experience nausea and vomiting due to chemotherapy.

Scope of the Report:

This report focuses on the Chemotherapy-induced Nausea and Vomiting Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes The market based on manufacturers, regions, type and application.
North America is the largest sales region of Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs

The worldwide market for Chemotherapy-induced Nausea and Vomiting Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

• GlaxoSmithKline
• Helsinn
• Heron Therapeutics
• Merck & Co
• Tesaro
• Acacia Pharma
• Aphios
• Barr Laboratories
• Baxter Healthcare
• Eisai
• Especificos Stendhal
• F.Hoffmann La Roche
• Mundipharma
• Mylan Pharmaceuticals
• OPKO Health
• Orchid Healthcare

Market Segment by Regions, regional analysis covers

• North America (United States, Canada and Mexico)
• Europe (Germany, France, UK, Russia and Italy)
• Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
• South America (Brazil, Argentina, Colombia etc.)
• Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

• Aloxi (palonosetron)
• Kytril Generic (granisetron)
• Emend (aprepitant)
• Akynzeo (netupitant-palonosetron)

Market Segment by Applications, can be divided into

• Blood Cancer
• Breast Cancer
• Gastrointestinal Tract Cancer
• Others

There are 15 Chapters to deeply display The global Chemotherapy-induced Nausea and Vomiting Drugs market.

Chapter 1, to describe Chemotherapy-induced Nausea and Vomiting Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Chemotherapy-induced Nausea and Vomiting Drugs, with sales, revenue, and price of Chemotherapy-induced Nausea and Vomiting Drugs, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show The global market by regions, with sales, revenue and market share of Chemotherapy-induced Nausea and Vomiting Drugs, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze The market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show The market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Chemotherapy-induced Nausea and Vomiting Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Chemotherapy-induced Nausea and Vomiting Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Contents

1 MARKET OVERVIEW

1.1 Chemotherapy-induced Nausea and Vomiting Drugs Introduction
1.2 Market Analysis by Type
  1.2.1 Aloxi (palonosetron)
  1.2.2 Kytril Generic (granisetron)
  1.2.3 Emend (aprepitant)
  1.2.4 Akynzeo (netupitant-palonosetron)
1.3 Market Analysis by Applications
  1.3.1 Blood Cancer
  1.3.2 Breast Cancer
  1.3.3 Gastrointestinal Tract Cancer
  1.3.4 Others
1.4 Market Analysis by Regions
  1.4.1 North America (United States, Canada and Mexico)
    1.4.1.1 United States Market States and Outlook (2013-2023)
    1.4.1.2 Canada Market States and Outlook (2013-2023)
    1.4.1.3 Mexico Market States and Outlook (2013-2023)
  1.4.2 Europe (Germany, France, UK, Russia and Italy)
    1.4.2.1 Germany Market States and Outlook (2013-2023)
    1.4.2.2 France Market States and Outlook (2013-2023)
    1.4.2.3 UK Market States and Outlook (2013-2023)
    1.4.2.4 Russia Market States and Outlook (2013-2023)
    1.4.2.5 Italy Market States and Outlook (2013-2023)
  1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    1.4.3.1 China Market States and Outlook (2013-2023)
    1.4.3.2 Japan Market States and Outlook (2013-2023)
    1.4.3.3 Korea Market States and Outlook (2013-2023)
    1.4.3.4 India Market States and Outlook (2013-2023)
    1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  1.4.4 South America, Middle East and Africa
    1.4.4.1 Brazil Market States and Outlook (2013-2023)
    1.4.4.2 Egypt Market States and Outlook (2013-2023)
    1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
    1.4.4.4 South Africa Market States and Outlook (2013-2023)
    1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
  1.5.1 Market Opportunities
  1.5.2 Market Risk
  1.5.3 Market Driving Force

2 MANUFACTURERS PROFILES

2.1 GlaxoSmithKline
  2.1.1 Business Overview
    2.1.1.1 GlaxoSmithKline Description
    2.1.1.2 GlaxoSmithKline Headquarter, Main Business and Finance Overview
  2.1.2 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.1.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.1.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.1.3 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.1 GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.1.3.2 Global GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.2 Helsinn
  2.2.1 Business Overview
    2.2.1.1 Helsinn Description
    2.2.1.2 Helsinn Headquarter, Main Business and Finance Overview
  2.2.2 Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.2.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.2.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.2.3 Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.1 Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2.3.2 Global Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.3 Heron Therapeutics
  2.3.1 Business Overview
    2.3.1.1 Heron Therapeutics Description
    2.3.1.2 Heron Therapeutics Headquarter, Main Business and Finance Overview
  2.3.2 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.3.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.3.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.3.3 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.1 Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3.3.2 Global Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.4 Merck & Co
  2.4.1 Business Overview
    2.4.1.1 Merck & Co Description
    2.4.1.2 Merck & Co Headquarter, Main Business and Finance Overview
  2.4.2 Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.4.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.4.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.4.3 Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.1 Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4.3.2 Global Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.5 Tesaro
  2.5.1 Business Overview
    2.5.1.1 Tesaro Description
    2.5.1.2 Tesaro Headquarter, Main Business and Finance Overview
  2.5.2 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.5.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.5.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.5.3 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.1 Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5.3.2 Global Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.6 Acacia Pharma
  2.6.1 Business Overview
    2.6.1.1 Acacia Pharma Description
    2.6.1.2 Acacia Pharma Headquarter, Main Business and Finance Overview
  2.6.2 Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.6.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.6.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.6.3 Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.1 Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6.3.2 Global Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.7 Aphios
  2.7.1 Business Overview
    2.7.1.1 Aphios Description
    2.7.1.2 Aphios Headquarter, Main Business and Finance Overview
  2.7.2 Aphios Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.7.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.7.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.7.3 Aphios Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.1 Aphios Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7.3.2 Global Aphios Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.8 Barr Laboratories
  2.8.1 Business Overview
    2.8.1.1 Barr Laboratories Description
    2.8.1.2 Barr Laboratories Headquarter, Main Business and Finance Overview
  2.8.2 Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.8.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.8.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.8.3 Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.1 Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8.3.2 Global Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.9 Baxter Healthcare
  2.9.1 Business Overview
    2.9.1.1 Baxter Healthcare Description
    2.9.1.2 Baxter Healthcare Headquarter, Main Business and Finance Overview
  2.9.2 Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.9.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.9.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.9.3 Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.1 Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9.3.2 Global Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.10 Eisai
  2.10.1 Business Overview
    2.10.1.1 Eisai Description
    2.10.1.2 Eisai Headquarter, Main Business and Finance Overview
  2.10.2 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
    2.10.2.1 Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
    2.10.2.2 Chemotherapy-induced Nausea and Vomiting Drugs Product Information
  2.10.3 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.1 Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10.3.2 Global Eisai Chemotherapy-induced Nausea and Vomiting Drugs Market Share in 2017
2.11 Especificos Stendhal
  2.11.1 Business Overview
  2.11.2 Especificos Stendhal Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.11.3 Especificos Stendhal Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 F.Hoffmann La Roche
  2.12.1 Business Overview
  2.12.2 F.Hoffmann La Roche Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.12.3 F.Hoffmann La Roche Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Mundipharma
  2.13.1 Business Overview
  2.13.2 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.13.3 Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.14 Mylan Pharmaceuticals
  2.14.1 Business Overview
  2.14.2 Mylan Pharmaceuticals Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.14.3 Mylan Pharmaceuticals Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.15 OPKO Health
  2.15.1 Business Overview
  2.15.2 OPKO Health Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.15.3 OPKO Health Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.16 Orchid Healthcare
  2.16.1 Business Overview
  2.16.2 Orchid Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Product Introduction
  2.16.3 Orchid Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET COMPETITION, BY MANUFACTURER

3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Manufacturer (2016-2017)
3.4 Market Concentration Rate
  3.4.1 Top 3 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer Market Share in 2017
  3.4.2 Top 5 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer Market Share in 2017
3.5 Market Competition Trend

4 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET ANALYSIS BY REGIONS

4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Regions
  4.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Regions (2013-2018)
  4.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Regions (2013-2018)
4.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2013-2018)
4.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2013-2018)
4.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2013-2018)
4.5 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2013-2018)
4.6 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2013-2018)

5 NORTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

5.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
  5.1.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
  5.1.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
  5.1.3 United States Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  5.1.4 Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  5.1.5 Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
5.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  5.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2016-2017)
  5.2.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2016-2017)
5.3 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  5.3.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Type (2013-2018)
  5.3.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Type (2013-2018)
5.4 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Application (2013-2018)
  5.4.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Application (2013-2018)
  5.4.2 North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Application (2013-2018)

6 EUROPE CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

6.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
  6.1.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
  6.1.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
  6.1.3 Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  6.1.4 UK Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  6.1.5 France Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  6.1.6 Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  6.1.7 Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
6.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  6.2.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2016-2017)
  6.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2016-2017)
6.3 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  6.3.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Type (2013-2018)
  6.3.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Type (2013-2018)
6.4 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Application (2013-2018)
  6.4.1 Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Application (2013-2018)
  6.4.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Application (2013-2018)

7 ASIA-PACIFIC CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

7.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
  7.1.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
  7.1.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
  7.1.3 China Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  7.1.4 Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  7.1.5 Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  7.1.6 India Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  7.1.7 Southeast Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
7.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  7.2.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2016-2017)
  7.2.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2016-2017)
7.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  7.3.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Type (2013-2018)
  7.3.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Type (2013-2018)
7.4 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Application (2013-2018)
  7.4.1 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Application (2013-2018)
  7.4.2 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Application (2013-2018)

8 SOUTH AMERICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

8.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
  8.1.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
  8.1.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
  8.1.3 Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  8.1.4 Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  8.1.5 Colombia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
8.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  8.2.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2016-2017)
  8.2.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2016-2017)
8.3 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  8.3.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Type (2013-2018)
  8.3.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Type (2013-2018)
8.4 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Application (2013-2018)
  8.4.1 South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Application (2013-2018)
  8.4.2 South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Application (2013-2018)

9 MIDDLE EAST AND AFRICA CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS BY COUNTRIES, TYPE, APPLICATION AND MANUFACTURERS

9.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Countries
  9.1.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
  9.1.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
  9.1.3 Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  9.1.4 UAE Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  9.1.5 Egypt Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  9.1.6 Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
  9.1.7 South Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
9.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Revenue (Value) by Manufacturers (2016-2017)
  9.2.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturers (2016-2017)
  9.2.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturers (2016-2017)
9.3 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  9.3.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Type (2013-2018)
  9.3.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Type (2013-2018)
9.4 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Application (2013-2018)
  9.4.1 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Sales Share by Application (2013-2018)
  9.4.2 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Revenue Share by Application (2013-2018)

10 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET SEGMENT BY TYPE

10.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Market Share by Type (2013-2018)
  10.1.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Market Share by Type (2013-2018)
  10.1.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2013-2018)
10.2 Aloxi (palonosetron) Sales Growth and Price
  10.2.1 Global Aloxi (palonosetron) Sales Growth (2013-2018)
  10.2.2 Global Aloxi (palonosetron) Price (2013-2018)
10.3 Kytril Generic (granisetron) Sales Growth and Price
  10.3.1 Global Kytril Generic (granisetron) Sales Growth (2013-2018)
  10.3.2 Global Kytril Generic (granisetron) Price (2013-2018)
10.4 Emend (aprepitant) Sales Growth and Price
  10.4.1 Global Emend (aprepitant) Sales Growth (2013-2018)
  10.4.2 Global Emend (aprepitant) Price (2013-2018)
10.5 Akynzeo (netupitant-palonosetron) Sales Growth and Price
  10.5.1 Global Akynzeo (netupitant-palonosetron) Sales Growth (2013-2018)
  10.5.2 Global Akynzeo (netupitant-palonosetron) Price (2013-2018)

11 GLOBAL CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET SEGMENT BY APPLICATION

11.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Application (2013-2018)
11.2 Blood Cancer Sales Growth (2013-2018)
11.3 Breast Cancer Sales Growth (2013-2018)
11.4 Gastrointestinal Tract Cancer Sales Growth (2013-2018)
11.5 Others Sales Growth (2013-2018)

12 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET FORECAST (2018-2023)

12.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Regions (2018-2023)
  12.2.1 North America Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
  12.2.2 Europe Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
  12.2.3 Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
  12.2.4 South America Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
  12.2.5 Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
12.3 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Type (2018-2023)
  12.3.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Type (2018-2023)
  12.3.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Type (2018-2023)
12.4 Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast by Application (2018-2023)
  12.4.1 Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Application (2018-2023)
  12.4.2 Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Application (2018-2023)

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
  13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Data Source

List Of Tables

LIST OF TABLES AND FIGURES

Figure Chemotherapy-induced Nausea and Vomiting Drugs Picture
Table Product Specifications of Chemotherapy-induced Nausea and Vomiting Drugs
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (USD Million)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs CAGR (%), Y-o-Y Growth (&) and Market Size, 2013-2023 (Sales)
Figure Global Sales Market Share of Chemotherapy-induced Nausea and Vomiting Drugs by Types in 2017
Figure Aloxi (palonosetron) Picture
Table Major Manufacturers of Aloxi (palonosetron)
Figure Kytril Generic (granisetron) Picture
Table Major Manufacturers of Kytril Generic (granisetron)
Figure Emend (aprepitant) Picture
Table Major Manufacturers of Emend (aprepitant)
Figure Akynzeo (netupitant-palonosetron) Picture
Table Major Manufacturers of Akynzeo (netupitant-palonosetron)
Figure Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Applications in 2017
Figure Blood Cancer Picture
Figure Breast Cancer Picture
Figure Gastrointestinal Tract Cancer Picture
Figure Others Picture
Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure France Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure China Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure India Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Revenue (Value) and Growth Rate (2013-2023)
Table GlaxoSmithKline Headquarter, Established, Main Business and Finance Overview (2017)
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Product
Table GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global GlaxoSmithKline Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Helsinn Headquarter, Established, Main Business and Finance Overview (2017)
Table Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Helsinn Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Heron Therapeutics Headquarter, Established, Main Business and Finance Overview (2017)
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Heron Therapeutics Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Merck & Co Headquarter, Established, Main Business and Finance Overview (2017)
Table Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Merck & Co Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Tesaro Headquarter, Established, Main Business and Finance Overview (2017)
Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Tesaro Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Acacia Pharma Headquarter, Established, Main Business and Finance Overview (2017)
Table Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Acacia Pharma Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Aphios Headquarter, Established, Main Business and Finance Overview (2017)
Table Aphios Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Aphios Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Aphios Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Aphios Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Aphios Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Barr Laboratories Headquarter, Established, Main Business and Finance Overview (2017)
Table Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Barr Laboratories Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Baxter Healthcare Headquarter, Established, Main Business and Finance Overview (2017)
Table Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Baxter Healthcare Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Eisai Headquarter, Established, Main Business and Finance Overview (2017)
Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Production Bases, Sales Regions and Major Competitors
Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Product
Table Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Figure Global Eisai Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share in 2017
Figure Global Eisai Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share in 2017
Table Especificos Stendhal
Table Especificos Stendhal Chemotherapy-induced Nausea and Vomiting Drugs
Table F.Hoffmann La Roche
Table F.Hoffmann La Roche Chemotherapy-induced Nausea and Vomiting Drugs
Table Mundipharma
Table Mundipharma Chemotherapy-induced Nausea and Vomiting Drugs
Table Mylan Pharmaceuticals
Table Mylan Pharmaceuticals Chemotherapy-induced Nausea and Vomiting Drugs
Table OPKO Health
Table OPKO Health Chemotherapy-induced Nausea and Vomiting Drugs
Table Orchid Healthcare
Table Orchid Healthcare Chemotherapy-induced Nausea and Vomiting Drugs
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Price by Manufacturer (2016-2017)
Figure Top 3 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Chemotherapy-induced Nausea and Vomiting Drugs Manufacturer (Revenue) Market Share in 2017
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Regions (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Regions (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Regions (2013-2018)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions in 2013
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Regions in 2017
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2013-2018)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2017
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2013-2018)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2013
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2017
Figure United States Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Canada Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Mexico Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2013-2018)
Table North America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2013-2018)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2016
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2017
Figure Germany Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure UK Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure France Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Russia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Italy Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2013-2018)
Table Europe Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2013-2018)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries 2017
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries 2017
Figure China Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Japan Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Korea Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure India Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Southeast Asia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2013-2018)
Table Asia-Pacific Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2013-2018)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2013-2018)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2017
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2013-2018)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2017
Figure Brazil Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Argentina Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Colombia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2013-2018)
Table South America Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2013-2018)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Countries (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Countries in 2017
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Countries (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2013
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Countries in 2017
Figure Saudi Arabia Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure UAE Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Egypt Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure Nigeria Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Figure South Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Manufacturer (2016-2017)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2016
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Market Share by Manufacturer in 2017
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Manufacturer (2016-2017)
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2016
Figure Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Market Share by Manufacturer in 2017
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Application (2013-2018)
Table Middle East and Africa Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Application (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Type (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue by Type (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Figure Global Aloxi (palonosetron) Sales Growth (2013-2018)
Figure Global Aloxi (palonosetron) Price (2013-2018)
Figure Global Kytril Generic (granisetron) Sales Growth (2013-2018)
Figure Global Kytril Generic (granisetron) Price (2013-2018)
Figure Global Emend (aprepitant) Sales Growth (2013-2018)
Figure Global Emend (aprepitant) Price (2013-2018)
Figure Global Akynzeo (netupitant-palonosetron) Sales Growth (2013-2018)
Figure Global Akynzeo (netupitant-palonosetron) Price (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales by Application (2013-2018)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Share by Application (2013-2018)
Figure Global Blood Cancer Sales Growth (2013-2018)
Figure Global Breast Cancer Sales Growth (2013-2018)
Figure Global Gastrointestinal Tract Cancer Sales Growth (2013-2018)
Figure Global Others Sales Growth (2013-2018)
Figure Global Chemotherapy-induced Nausea and Vomiting Drugs Sales, Revenue and Growth Rate (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Regions (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Regions (2018-2023)
Figure North America Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
Figure Europe Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
Figure Asia-Pacific Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
Figure South America Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
Figure Middle East and Africa Sales Chemotherapy-induced Nausea and Vomiting Drugs Market Forecast (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Type (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Type (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Sales Forecast by Application (2018-2023)
Table Global Chemotherapy-induced Nausea and Vomiting Drugs Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List